Study rationale and design of ADVANCE: Action in diabetes and vascular disease - Preterax and diamicron MR controlled evaluation

J. Chalmers, M. Cooper, E. Ferrannini, P. Glasziou, D. Grobbee, P. Hamet, S. Harrap, L. Liu, S. MacMahon, G. Mancia, M. Marre, D. Matthews, C. Mogensen, B. Neal, C. Yu Pan, N. Poulter, A. Rodgers, B. Williams, M. Woodward, R. CollinsP. Sandercock, P. Sleight, R. Holman, G. Fulcher, C. Pollock, D. Celermajer, J. Watson, B. Harrisberg, R. Currie, S. Girgis, K. Jayne, H. Monaghan, A. Patel, A. Richens, B. Gray, A. Milne, A. Adderkin, A. Bak, S. Flett, D. De Guise, E. Jetses, J. Reid, R. Stolk, W. Wang, F. Williams, X. Zou

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Study rationale and design of ADVANCE: Action in diabetes and vascular disease - Preterax and diamicron MR controlled evaluation'. Together they form a unique fingerprint.

Medicine & Life Sciences